| Names | |
|---|---|
| Other names | MAP L-Ascorbic Acid, Magnesium Salt Magnesium Salt of Ascorbic Acid Magnesium L-ascorbyl-2-phosphate |
| Pronunciation | /maɡˈniːziəm əˈskɔːrbɪl fəˈsfeɪt/ |
| Identifiers | |
| CAS Number | 114040-31-2 |
| Beilstein Reference | 3681233 |
| ChEBI | CHEBI:63013 |
| ChEMBL | CHEMBL3184849 |
| ChemSpider | 22217 |
| DrugBank | DB11362 |
| ECHA InfoCard | 13f42e70-c2ef-4e39-92b4-5e8d2074c22e |
| EC Number | EC 299-166-6 |
| Gmelin Reference | 96985 |
| KEGG | C02345 |
| MeSH | D020350 |
| PubChem CID | 3034393 |
| RTECS number | RR0350000 |
| UNII | 1V05ENI77A |
| UN number | UN1993 |
| CompTox Dashboard (EPA) | DJ27M07834 |
| Properties | |
| Chemical formula | C6H6O9P2Mg |
| Molar mass | 222.55 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 0.5 g/cm3 |
| Solubility in water | Soluble in water |
| log P | 0.94 |
| Vapor pressure | Negligible |
| Acidity (pKa) | 7.0 |
| Basicity (pKb) | 10.20 |
| Magnetic susceptibility (χ) | Diamagnetic |
| Refractive index (nD) | 1.445 |
| Viscosity | Viscous liquid |
| Dipole moment | 9.645 D |
| Pharmacology | |
| ATC code | A11GA04 |
| Hazards | |
| Main hazards | May cause eye, skin, and respiratory irritation. |
| GHS labelling | GHS labelling: Not classified as hazardous according to GHS. |
| Pictograms | GHS07 |
| Hazard statements | May cause slight irritation to the skin and eyes. |
| Precautionary statements | P264, P270, P280, P301+P312, P330, P501 |
| Explosive limits | Non-explosive |
| LD50 (median dose) | LD50 (rat, oral) > 5,000 mg/kg |
| NIOSH | Not Listed |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.2-3% |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds | Ascorbic acid Sodium ascorbyl phosphate Calcium ascorbate Magnesium ascorbate Ascorbyl palmitate |
| Product Identification | Industrial Commentary |
|---|---|
| Product Name Magnesium Ascorbyl Phosphate |
Magnesium Ascorbyl Phosphate is a stabilized vitamin C derivative. In our production lines, it behaves reliably in powder and granule processing, with moisture content and residual solvents closely monitored to maintain intended activity. Lab personnel focus on surface area, bulk density, and flowability during the final stages to align with downstream blending requirements. |
| IUPAC Name Magnesium [(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl]methyl phosphate |
The IUPAC designation reflects the molecular structure found in our validated batch records. The configuration of the base ascorbic acid skeleton and magnesium phosphate functionalization guide our process route selection, especially in precipitation and purification steps. Our route eliminates non-reacted phosphate and ascorbate residues based on HPLC analytical feedback. |
| Chemical Formula C6H7O9P·Mg |
We confirm the gross chemical formula as part of compound characterization. Grade-specific lots are checked for magnesium to ascorbate ratio, which can shift if water of hydration remains after crystallization. The degree of hydration is regulated by the drying step, which impacts storage life and caking tendencies in industrial handling. |
| Synonyms & Trade Names MAP; Magnesium L-ascorbyl-2-phosphate; L-Ascorbic acid magnesium salt; Ascorbyl magnesium phosphate |
Synonym usage depends on application context and regional convention. Cosmetic ingredient lists typically use MAP, regulatory registrations favor the IUPAC or INCI format, and trade forms differ based on customer-specific branding and required documentation. All batches adhere to internal traceability policy to ensure synonym reconciliation across technical, sales, and shipping documents. |
| HS Code & Customs Classification 2936.27 |
HS code assignment falls under ‘Provitamins and vitamins, natural or reproduced by synthesis’. Border declaration uses code 2936.27 for phosphate derivatives of vitamin C. Customs compliance requires documentation of grade and purity; typical differences in regional customs audits center on declared assay grades and unit packaging for import control. Production lots intended for international shipment align documentation with the receiving country’s regulatory language and pharmaceutical/cosmetic designation if required by law. |
Industrial-grade magnesium ascorbyl phosphate typically appears as a white to off-white powder with no discernible odor. Subtle color drift may occur depending on raw material quality and process hygiene. Texture and flowability can shift with particle size distribution, which is adjusted for specific applications. The melting and boiling points are rarely specified due to the product’s decomposition before reaching either transition, and bulk density depends on granulation and drying parameters set by the process. Densities and appearances are fine-tuned for either cosmetic, food, or pharmaceutical requirements, so no single figure applies across grades.
Shelf stability stems from low hygroscopicity and chemical inertness at ambient temperatures. The compound resists atmospheric oxygen and does not hydrolyze rapidly under dry conditions. Reactivity increases in the presence of moisture, strong acids, or bases, which can trigger hydrolysis or degradation into ascorbic acid and phosphate salts. Grade differences emerge from stabilizer content and permissible moisture, impacting reactivity profiles in end formulations. Storage and transit conditions directly impact this stability, requiring firm control as part of quality assurance.
Solubility in water ranks as moderate, with dissolution kinetics influenced by pH, temperature, and agitation. For formulation work, pre-wetting or pH adjustment optimizes dissolution rate and clarity. Higher-purity pharmaceutical and cosmetic grades require finer particles for better dispersion; certain applications demand pre-clarified or filtered solutions. Residual undissolved fraction and particulates correlate with grade and source.
Quality parameters are not uniform but are defined per grade—cosmetic, food, or pharmaceutical. Common parameters include identification (by IR or HPLC), assay for active content, loss on drying, heavy metal content, and microbial load. Final specification tables follow internal quality standards or are set in consultation with the client.
Impurity profiles are controlled heavily by raw material purity, equipment cleanliness, and process conditions. Key attention points include unreacted ascorbic acid, inorganic phosphate, and magnesium salts, which can originate from incomplete reaction or over-neutralization. Impurity limits are dictated by application requirements: pharmaceuticals require the strictest controls, cosmetics less so, and food grades follow food safety regulations. Regular impurity trend monitoring uses validated chromatographic or spectroscopic methods.
Quality control laboratories utilize titrimetric, chromatographic, and spectrophotometric methods for content and impurity determination. Reference compendia (pharmacopeia, food standards) are consulted where available, but manufacturer-specific validated protocols often form the release criteria for internal and external compliance.
Raw material selection focuses on pharma- or food-grade ascorbic acid, high-purity magnesium oxide or hydroxide, and phosphoric acid. The quality and traceability of these inputs set the baseline for final product purity. Sourcing involves vendor qualification with attention to elemental impurities and potential bioburden.
Manufacturing relies on phosphorylating ascorbic acid in a controlled alkaline environment, using magnesium salt as both pH buffer and reactant. Process steps include dissolution, controlled reagent addition, pH management, and regulated temperature, followed by precipitation and filtration. The reaction sequence promotes selective phosphorylation at the 2-position of ascorbic acid, but byproduct formation (including ascorbic acid degradation and over-phosphorylation) remains a risk.
Key control points include pH, temperature, addition speed, and order of reactant addition. Byproducts and unreacted precursors are removed via selective washing and crystallization. Continuous in-process sampling checks impurity drift and yield consistency. Upstream process modifications, such as micronization of raw ascorbic acid, can reduce recrystallization inefficiency. Purification protocols change for higher-purity pharmaceutical manufacture, sometimes requiring additional solubilization and re-precipitation cycles.
Each batch’s release hinges on tight compliance with agreed technical criteria—assay, impurity panel, particle size, microbiological limits. End-use application determines final cutoffs. Out-of-spec outcomes prompt root cause analysis, often reimbursed by raw material variation or deviation in pH trajectory during synthesis.
Magnesium ascorbyl phosphate demonstrates stability in neutral to mildly alkaline conditions, yet will hydrolyze under acidic or strongly alkaline conditions, regenerating ascorbic acid and releasing phosphate and magnesium ions. Reaction rates accelerate at elevated temperature and extremes of pH.
Catalysis and solvents are rarely employed industrially, but water content and ionic strength strongly influence solution-phase stability and hydrolysis speed. Downstream processing can leverage pH-triggered hydrolysis to generate ascorbic acid in situ for controlled-release formulations. Process optimization focuses on temperature-control to slow unwanted transformation and byproduct buildup.
Magnesium ascorbyl phosphate functions as a precursor for stabilized vitamin C delivery in creams, serums, and supplements. Its structural phosphate moiety can be displaced under specific reaction conditions, offering modification points for developers of next-generation antioxidants or phosphate removal variants tailored for application compatibility.
Product longevity is safeguarded by reducing exposure to moisture, elevated temperature, light, and acidic vapors. Warehousing infrastructure incorporates desiccant controls and non-transparent packaging. Batch segregation and local humidity monitoring help maintain stability within the intended shelf life.
Direct contact with ferrous metals or reactive plastics is avoided due to potential for trace metal catalyzed decomposition. Food-grade polyethylene or multilayer barrier bags suffice for most commercial formats. Compatibility testing may be warranted for bulk returns or new drum suppliers.
Product shelf life remains grade- and storage-dependent. Loss of whiteness, caking, or development of an acidic or off odor signals hydrolysis or microbial compromise, typically stemming from packaging breach or temperature deviation. Periodic retesting of retained samples sets the standard for re-qualification and inventory rollover.
As a manufacturer, GHS hazard classification references the blend of raw material and product hazard statements. The compound rarely triggers acute hazard pictograms but may be flagged for eye or skin irritancy at high concentration. End-use handling instructions aim to minimize dust generation and direct contact.
Practical handling advises against inhalation of dust and recommends skin and eye protection during production transfer and post-fill packaging. Washing facilities at points of use enable first aid for unintended contact.
Toxicity studies reference those for ascorbic acid and phosphate, which present a low risk profile at typical exposure concentrations, though data review adjusts for process-driven trace impurities and grade-specific content. Special attention is paid to nanoparticulate forms or excessive dust levels, which may impact pulmonary exposure risk.
No formal occupational exposure limit for magnesium ascorbyl phosphate is typically enforced, but nuisance dust limits for inert particulate guide on-site environmental controls. Production environments may implement local extraction, respiratory PPE, and periodic air monitoring, particularly during sieving, transfer, and bagging operations. Safety data sheets detail emergency measures and regulatory positioning per regional compliance.
Commercial production of Magnesium Ascorbyl Phosphate (MAP) relies on both raw material availability and technical optimization of the phosphate esterification process. Capacity varies depending on synthesis route, batch size, and the specific purity requirements set by the customer. In high-purity grades, capacity bottlenecks often relate to purification and filtration throughput rather than synthesis step yield. For multi-grade producers, line changeover timing can influence short-term availability. During periods of market imbalance—frequent in the personal care and cosmetics ingredient sector—lead times for specialty or cosmetic grades increase as upstream intermediates become short or demand surges suddenly from contract manufacturers.
Lead times range from immediate for stock items to up to several weeks for custom specification lots or high-purity grades, especially when subject to batch release according to client test criteria. Minimum order quantities (MOQ) depend on the granulation, packaging configuration, and grade requirements; pharmaceutical and cosmetic grades tend toward higher MOQs due to cleaning validation and dedicated batch runs. Technical grade typically allows more flexibility in lot size and order frequency.
Packaging must protect MAP’s ascorbate component from hydrolysis and oxidation. Drum, fiberboard, or HDPE pails with inner polyethylene liners are standard for bulk orders. For cosmetic and pharmaceutical users, nitrogen-purged packaging or vacuum sealing may be specified to maintain shelf stability. Primary packaging selection depends on both grade specification and transport route regulatory requirements.
Transportation mode relates directly to packaging and regulatory status, with temperature and humidity control more strictly enforced on high-purity MAP. Payment terms follow industry custom—net 30, LC at sight, or CAD for new customers—subject to credit review. Export shipments must comply with local and destination documentation requirements, including safety and hazard labeling where relevant to bulk MAP.
The primary input cost for MAP is high-purity ascorbic acid and magnesium salts. Volatility in global vitamin C production, which concentrated in China, directly impacts MAP’s cost base. Phosphorylation reagents cost fluctuates with energy pricing and intermediate commodity chemicals. Costs escalate sharply for grades requiring controlled trace metal levels and low residual solvents due to extra refinement.
Raw material supply disruptions—maintenance shutdowns, pollution control interventions, or spikes in energy prices—tend to echo through MAP pricing especially for cosmetic and pharmaceutical users who require additional documentation and batch traceability.
MAP pricing demonstrates pronounced differences by grade. Cosmetic and pharmaceutical grades command higher prices due to narrower impurity profiles, batchwise testing for heavy metals and microbial content, and documentation for REACH or US FDA compliance. Bulk technical grade prices reflect only base input costs and standard plant certification, with less frequent analytical release testing. Packaging variations—such as nitrogen-purged or vacuum-sealed lining—add linearly to cost, as do certificates of analysis, GMP compliance documentation, and customer-specific batch reserve or recall procedures.
MAP demand holds steady in personal care, where it persists as a preferred stable vitamin C derivative for whitening and antioxidant functions in formulations. Production capacity remains concentrated in China for both technical and high-purity grades, while US, EU, and Japan typically operate local packing and release under more stringent compliance systems.
US and EU markets focus on certified, traceable product—demanding robust documentation and regulatory alignment, driving higher average price points. Japanese buyers show preference for ultra-low impurity profiles and custom packaging, establishing a smaller but premium segment. India’s production focuses on price competitiveness, usually on technical and export ingredients, rather than premium cosmetic applications. China remains the central supplier, driving both spot and contract pricing for raw materials and intermediates.
MAP pricing is projected to edge upward by 2026, primarily due to expected increases in ascorbic acid feedstock costs, persistent energy price volatility, and more stringent regulatory testing for cosmetic and pharma grades worldwide. While margin pressure may soften for technical grades as new regional players enter, premium grades face inflationary input costs and escalating compliance investments.
Forecast draws on proprietary market tracking, published statistics on Chinese vitamin C output, energy price indices, global chemical trade flows, customer inquiry volume analysis, and regional regulatory bulletin monitoring.
Recent disruptions in vitamin C production in Northern China have raised MAP producers’ risk management profiles, prompting stronger commitments to dual sourcing and greater stockholding, especially for regional distributors serving cosmetics majors.
EU and North American authorities are tightening controls on heavy metal content and residual solvent levels, reflected in new testing frequency and release record requirements for cosmetic grade MAP, pushing up batchwise testing costs. Updates to REACH and US TSCA registration criteria require more granular documentation and impurity tracing for MAP imported into these regions. Japan’s reporting regime on cosmetic ingredient traceability remains among the strictest globally, driving demand for high-conformance documentation and quality assurance procedures.
To manage these changes, manufacturers invest in process optimization to reduce impurity formation and increase first-pass yield for high-purity MAP. Automation of in-process testing shortens batch review cycles. Expanded warehouse facilities near export ports help buffer against intermittent feedstock delays. Increased frequency of internal audits and third-party inspections forms the backbone of ongoing compliance and quality assurance initiatives intended to support downstream customer requirements in evolving regulatory environments.
Magnesium Ascorbyl Phosphate (MAP) serves distinct roles across cosmetic, pharmaceutical, and personal care industries. In the cosmetics sector, formulators turn to MAP for advanced skin brightening systems and antioxidant creams, where appearance and stability of the end product hold high importance. Pharmaceutical uses focus on topical preparations that address photoaging and skin irritation, demanding high batch-to-batch consistency and low impurity levels. In oral care, MAP finds favor in toothpaste and mouthwashes, where stability toward hydrolysis during production and shelf life needs verification.
| Application Field | Typical Grade Requirements | Main Parameter Focus |
|---|---|---|
| Cosmetic Formulation | Cosmetic or Hyaluronic-compatible Grades | Appearance, particle size, organoleptic stability, oxidative stability |
| Pharmaceutical Topicals | Pharma Grade | Assay, low heavy metals, residual solvent profile, microbiological profile |
| Oral Care | Toothpaste Grade or Food-compliant Grade | pH-stability, compatibility with abrasives, reactivity with fluorides and flavorants |
| Industrial & Technical | Technical Grade (where permissible) | Assay, solubility, process yield, non-critical for low-level cosmetic/industrial blends |
Cosmetic formulations test each batch for color, particle flow, and organoleptic behavior during mixing; cloudiness or off-odors signal carrier or intermediate breakdown. Pharmaceutical processes set stricter limits on assay, total impurity content, and element-specific residues. Oral care formulations rely on both chemical purity and compatibility with surfactants and abrasives—the wrong grade can trigger instability or precipitation on storage. Industrial uses emphasize processability, bulk properties, and handling under various humidity and temperature regimes; in these cases, the grade selected addresses throughput and purity more than safety endpoints.
The end use dictates many choices. Creams and lotions benefit from a fine, free-flowing powder that disperses quickly and resists yellowing over time. Oral gels and pastes sometimes impose secondary process steps, like high-shear mixing, which magnify any difference in physical grade or stabilizer system. Topical pharmaceutical formulations require a grade validated for low bioburden and controlled mineral content.
Manufacturing facilities address local and international norms—self-certification often works for cosmetic-only applications; regulated medical and OTC pharma lines require documented compliance with regional pharmacopeias or food additive listings. Always confirm allowable impurity limits and identity testing protocols before scaling up.
Assay and total impurity levels vary with synthesis route and raw material sourcing. Grades destined for sensitive skin or mucosal contact require extra purification to remove transition metals and water-soluble byproducts. Less pure technical grades might show higher residuals from phosphoric acid or secondary magnesium salts.
Production scale steers the grade choice. Large batch processes often accept slightly broader specifications on appearance or flow, trading off cost efficiency for performance. Niche applications, like luxury cosmeceuticals, usually specify a tighter grade even in small lots.
Manufacturers recommend sample evaluation before commitment. Variability from raw material lots, process route, or storage can impact performance in the final formulation. Testing small-scale batches under intended process conditions provides data for final selection. Production, quality, and technical teams advise adjusting grade based on formulation data, yield feedback, and shelf-life stress testing.
As an industrial-scale manufacturer of Magnesium Ascorbyl Phosphate, our operations align with internationally recognized quality management standards. Certification audits drive our commitment to in-plant discipline, traceability, and documentation rigor. Evaluation points include batch recordkeeping, deviation handling, and material traceability from each approved supplier through to finished goods. Internal audits focus on calibration, preventive maintenance, and change control in areas where process control or raw material integrity impact the final product grade.
Product certification requirements depend on the downstream application, origin requirements, and customer or regulatory agency expectations. For shipments destined for cosmetics, food, or pharma, documentation packages may include analytical method validation, statement of origin, and allergen declarations, customized by batch as needed. Regulatory submission support covers ingredient listings, restricted substance statements, and—where process or raw source changes occur—the issuing of updated impurity risk assessments.
Each lot receives an internal lot-specific certificate of analysis based on release testing against agreed criteria. Release specifications—including assay, purity, and moisture—are adjusted case by case for the application or region. Standard documentation includes safety data sheets, RoHS, and REACH statements where required, along with full traceability reports on request. For customer-specific batches or new application routes, test method adaptation and third-party validation can be coordinated through the QA/QC department.
Factory operating capacity planning addresses both regular purchase cycles and fluctuating forecast demand profiles. For key accounts or volume-sensitive partners, production planning links directly with forecasted requirements, keeping buffer stock in finished or semi-finished states. Flexible supply agreements range from standard quarterly cycles to just-in-time delivery schedules, with options for formula pack-down, special grade restriction, or private labeling where warranted by order scale or application need.
Base capacity relies on raw material supply contracts backed by long-term supplier agreements, ensuring security through primary and secondary source qualification. In-process control steps include monitoring of pH, temperature, and particulate levels at defined points, with each step adjusted for the required purity grade. For export markets or highly regulated regions, finished batch inventory is held pending external release, depending on shipment compliance or inspector review.
Samples are fabricated at pilot or main line scale, with the process flow mapped to mimic expected large-batch characteristics unless otherwise defined by the sample request. Each sample undergoes the same QC release as commercial lots, generating a batch-specific report. Standard sample quantities depend on the end use scenario; larger development projects can be assigned to the pilot lab for multi-sample evaluation under customer-specific technical criteria.
Agreement structures can vary by customer scenario—options include toll manufacturing, joint technical verification programs, and supply under mutual exclusivity or volume commitment terms. Embedded technical support includes on-site or remote troubleshooting, application development, and adjustment of purity or physical form on a development or ongoing basis. Batch scheduling, shipment packaging, and documentation templates can be tailored per customer SOPs for companies with unique internal processes or regulatory expectations.
Demand for vitamin C derivatives continues to drive innovation in magnesium ascorbyl phosphate synthesis and formulation integration. Industry and scientific research both target improved aqueous solubility, enhanced oxidative stability, and superior skin bioavailability. Manufacturers with in-house capabilities prioritize selection of ascorbic acid and magnesium reagents with consistent purity. Batch reproducibility takes priority for cosmetic and dermatological customers, who evaluate stability under light, heat, and packaging stresses. Production teams monitor crystal form, particle size, and pH control, as these have direct downstream effects on formulation compatibility.
The primary sector remains personal care, especially formulations requiring enhanced vitamin C stability. Besides traditional topical serums and creams, we track increased uptake in leave-on, rinse-off, and pre-mixed aqueous products. Companies developing skin-lightening solutions and sun care products now request grades with tailored particle morphologies for dispersion stability and reduced reactivity in layered systems. Some nutritional supplement manufacturers experiment with encapsulated or slow-release formats, seeking to leverage magnesium ascorbyl phosphate’s resistance to oxidation.
Process control around pH, reaction time, and water content sets the boundary for successful scale-up. Incomplete conversion, colored by-products, and filterability problems often trace back to raw material batch variability or in-line mixing precision. Increased focus on green chemistry compels modification of solvent and wash cycles, minimizing mother liquor waste and optimizing magnesium reagent recovery. New filtration and crystallization methods—such as membrane-assisted separation—aid in improving batch yield and impurity profile. Process analytical tools supporting real-time monitoring have shown practical benefits for quality assurance.
Magnesium ascorbyl phosphate shows steady demand trajectory, primarily fueled by continuous growth in premium skincare and wellness products in Asia, Europe, and North America. Regulatory acceptance in cosmetic markets and a rising consumer preference for stabilized vitamin C over traditional ascorbic acid underpins this expansion. Price fluctuations in ascorbic acid and energy input costs affect margin sensitivity, making efficiency in raw material sourcing and conversion yield a higher priority.
Shifts toward continuous processing and greater in-process automation allow manufacturers to tighten impurity profiles and batch-to-batch consistency beyond legacy batch methods. Downstream purification is evolving, with more reliance on multistage filtration and ion exchange over traditional precipitation-wash approaches. As customers specify stricter limits for trace metal and chloride residues, granular documentation and adaptive analytical methods have become standard.
Sustainable manufacturing focuses on reduced water consumption, energy-efficient crystallization, and magnesium waste recycling. In-house R&D targets closed-loop uses for magnesium co-products, and green solvents are under continuous screening. Lifecycle assessment for magnesium ascorbyl phosphate now considers not just carbon emissions but also water footprint and effluent load; process changes undergo environmental impact review before scale-up.
Direct access to formulation and analytical technical teams accelerates troubleshooting and scale-up. Manufacturers maintain a database of historical process deviations, enabling rapid root-cause analysis for customer-reported discoloration, solubility changes, or packaging incompatibility. Joint-development projects sometimes include on-site visits or remote analytical data review depending on confidentiality and project size.
Support covers pre-formulation assessment, compatibility studies, and stress testing under real-use conditions. Teams assist with adjusting process parameters to improve dispersibility, reduce foaming, or meet targeted magnesium release rates. Larger bulk customers may request technical review of downstream mixing, stability under fill-finish conditions, and assistance with regulatory documentation or shelf life testing, as required under different international cosmetic standards.
Commitment to batch recall traceability and long-term retention samples is standard. Any product deviation triggers joint investigation until resolution, with findings formally reported. Proactive change notification is practiced for specification or process shifts. Technical files include guidance on recommended analytical test methods, sampling regimen, and storage temperature range, defined according to grade and application-critical factors. Ongoing partnerships with key clients result in updated documentation and annual technical exchange meetings.
As a direct manufacturer of Magnesium Ascorbyl Phosphate (MAP), our production lines maintain full control over each stage of synthesis, refinement, and finishing. MAP combines the stability of a phosphate group with the biological advantages of Vitamin C, which has positioned it as a preferred option in skin care, personal care, and cosmetic formulations. By managing processing in-house, we guarantee the exact stoichiometry and purity levels required for consistent performance across complex end formulations.
Our focus remains on producing MAP that addresses the requirements set by cosmetic and personal care sectors, including skin brightening creams, serums, and sunscreen systems. MAP withstands oxidation much better than pure ascorbic acid, which solves the major challenge of maintaining Vitamin C activity in both water-based and emulsified bases. Many formulators seek to improve shelf life and visual stability, and our MAP production lines calibrate pH and particle size distribution to minimize product discoloration and sedimentation.
In addition to topical cosmetics, MAP supports water-soluble and temperature-resilient delivery in medical device coatings and oral care products. Chemical compatibility and batch-to-batch reproducibility remain core design parameters during scale-up.
Onsite laboratories conduct multi-point quality checks, covering assay, heavy metals, and oxidative stability throughout production. We do not depend on external labs for validation, which lets us identify and resolve deviations before packing. Our manufacturing team keeps analytical records linked to each lot, which helps with traceability when buyers require documentation for regulatory submission or client audits. Through vertical integration, each drum and carton rolling out of the plant delivers on the specification targets.
Industrial customers often demand larger pack formats to support continuous manufacturing lines. We fill MAP in sealed, moisture-controlled fiber drums and high barrier cartons with custom lining on request, minimizing exposure risks during transit and storage. Freight teams handle palletization and documentation to meet sea and air shipping protocols. By overseeing warehousing and outbound logistics, we support clients with predictable lead times for shipments to North America, Europe, and Asia.
Many commercial partners seek more than commodity material. Our technical support covers application-specific MAP grades, compatibility studies, and troubleshooting for emulsification, particle dispersion, and stability in product systems facing unique formulation hurdles. Application scientists are available for method verification, which shortens the trial phase and brings new finished products to market faster.
By managing production, QA, and international logistics under one roof, we help manufacturers, authorized distribution partners, and procurement managers streamline sourcing and compliance procedures. Fewer variables mean fewer interruptions—whether loading a new project pipeline or scaling existing brands. Lot traceability, shelf life data, and regulatory support remove uncertainty from purchasing cycles and facilitate smoother cooperation with downstream brand owners and OEMs.
MAP remains a critical ingredient for forward-looking brands investing in active, differentiated product lines. Our manufacturing approach ensures not only high material availability but also a supply chain link that adapts to market and technical developments.
Magnesium Ascorbyl Phosphate (MAP) enters our production line in the form of a carefully controlled white powder. As direct manufacturers, we keep a close eye on the particle size, fully aware of its impact on the final cosmetic product. Our experience with numerous formulation projects highlights how smaller particle sizes distribute better in emulsions and suspensions. For typical cosmetic applications, we target D50 values below 20 microns, with the majority of particles falling between 5 and 15 microns. This range assists formulators who demand smooth, non-gritty textures, whether crafting serums, emulsions, or pressed powders. Through consistent sieve analysis and laser diffraction, we ensure that our MAP meets these physical requirements batch after batch.
Challenges with particle size variation often show up during stability testing. Oversized particles can cause suspension separation or settling in gels and creams. Undersized particles, on the other hand, sometimes produce unwanted dustiness or complicate handling during large-scale batching. Years of direct feedback from R&D teams and production managers guide our process improvement. By adjusting milling parameters and performing in-process sieving, we keep particle size deviation within tight limits, minimizing issues downstream.
The active content of our Magnesium Ascorbyl Phosphate drives most conversations between our technical team and cosmetic clients. We routinely test every lot using validated high-performance liquid chromatography to certify MAP content. Our manufacturing process achieves an assay range of 98.0% to 102.0% as Magnesium Ascorbyl Phosphate on a dry basis. Values under this window could signal hydrolysis or incomplete reactions, so we maintain a robust analytical workflow from raw materials through finished powder.
Assay accuracy assures formulators that MAP delivers the expected antioxidant benefits at intended dosage levels. Insufficient content compromises product claims while excess can lead to budget leaks or regulatory questions. Tracking assay performance helps us identify process drift before it hits our inventory, reducing wastage and supporting our sustainability aims.
The industry always finds new ways to challenge production methods. Demands for ultrafine powders for spray lotions, or requests for coarse grades for unique dispensing systems, push our technical team to review and develop custom grades. We encourage open dialogue on trial batch performance and formulation outcomes, using this feedback cycle to optimize both particle size and active content with every production run.
Beyond the physical and chemical standards, MAP’s light sensitivity and hydration stability require special attention. Our powder ships in opaque, moisture-controlled packaging, based on recommendations from both long-term storage trials and in-field monitoring. Controlled humidity and temperature during storage and shipping preserve both the particle integrity and assay results over extended logistics timelines.
We back all shipments with batch-specific Certificates of Analysis, and welcome technical inquiries on compatibility or formulation troubleshooting. Our team draws on years of hands-on production experience and direct collaboration with cosmetic chemists, so formulation challenges get addressed promptly and precisely.
Magnesium ascorbyl phosphate has strong demand in personal care and cosmetic formulations. Bulk procurement of specialty ingredients like this always raises questions around minimum order quantities and production lead times. From our position as the direct manufacturer, consistent and transparent procurement processes support efficient production and reliable deliveries.
We operate large-scale synthesis and finishing lines designed to supply customers who require substantial volumes. Our minimum order quantity for magnesium ascorbyl phosphate sits at 25 kilograms. Below this threshold, production costs per unit escalate and logistics become inefficient, both for us and for the customer. A MOQ aligns our output with industry needs—R&D sample orders for smaller amounts are managed separately by our technical team to promote formulation trials and new product development.
Our standard lead time for bulk magnesium ascorbyl phosphate is 4-6 weeks from confirmed purchase order and completion of technical documentation. This schedule factors in all manufacturing stages, including raw material procurement, synthesis, QC testing, drying, milling, and standardized packaging to customer specification. For orders above the standard MOQ, delivery time may adjust slightly; our logistics coordination team works in advance to streamline shipments, especially on sea freight or international routes.
Alignment between the production plan and customer forecast is critical. Magnesium ascorbyl phosphate production involves specialized process controls and equipment turnaround. By communicating order requirements early, our team integrates forecasted demand into our production schedule to avoid bottlenecks and material shortages. We welcome annual or quarterly procurement planning, which helps us maintain buffer inventory and minimize response times for high-volume partners.
Bulk product usually ships in fiber drums or high-density polyethylene containers with food-grade liners to protect product quality during transit and storage. For multi-site operations or contract manufacturers, we offer packaging customization—logo labeling, palletization preferences, and certificates of analysis are managed in-house. Our documentation staff can prepare shipping and regulatory compliance paperwork tailored to international cosmetics and personal care standards.
Steady demand from global brands keeps our focus on production consistency and process optimization. Regular feedback collected by our technical and sales teams results in tighter process control and packaging improvements, reducing risk of supply interruption. We monitor our raw material suppliers closely, so even during busy seasons, our magnesium ascorbyl phosphate output remains steady and meets agreed turnaround times. If customers anticipate future spikes in demand, our capacity planning team can adjust batch sizes and run frequency to help meet heavier call-offs.
Direct communication with our plant engineers and logistics staff always produces the best results. By centralizing support, we eliminate delays caused by intermediaries or unclear specifications. Our procurement process prioritizes transparency and technical support, so commercial partners know exactly what to expect at every stage—from order forecasting and MOQ to shipment tracking and after-sales technical support.
Meeting REACH regulatory requirements represents a core principle in the way we operate as a manufacturer of Magnesium Ascorbyl Phosphate. Our production adheres to annual audits and strict raw material traceability to ensure robust compliance. We register our raw materials and end products in accordance with the latest chemical safety standards, and manage pre-registration updates as European legislation evolves. Documentation supporting these efforts is always current, maintained in both internal and official portals, and made available for audit or partner due diligence. Regulatory transparency and control over the complete supply chain foster long-term business continuity and customer trust.
Our team prepares the SDS for Magnesium Ascorbyl Phosphate by starting from the actual batch characteristics, then cross-verifies each section for accuracy against global and regional regulatory frameworks. Every SDS contains all compositional and toxicological details—in line with our practical knowledge and standard industrial hazards experienced in the factory environment. Handling guidance reflects lessons learned both on the shop floor and through customer feedback. The transport and storage instructions factor in our experience with temperature stability, packaging integrity, and incompatibility with certain industrial chemicals. Immediate availability of the SDS supports rapid project initiation for our partners and demonstrates technical responsibility on our part.
A CoA for Magnesium Ascorbyl Phosphate is issued from our in-house laboratory for each production lot. We use calibrated instruments to track assay, moisture, pH, and impurity profiles, then record all readings directly in the batch report. We verify the consistency against specification limits set through R&D and large-scale manufacturing practice. By linking CoA results to a specific batch, we prevent mix-ups and facilitate precise recall action if ever required. We see this documentation not simply as a formality but as a living record of manufacturing performance and continual improvement.
Industrial buyers count on traceable, fully compliant ingredients. We have seen persistent requests from both multinational and smaller customers for documentary evidence before placing orders. The demand for REACH compliance, coupled with thorough SDS and batch-level CoA, reflects modern market expectations. Consolidated records, swift access, and willingness to answer detailed technical queries address not only regulatory needs but also drive competitive advantage. As supply chain scrutiny increases, direct access to source documentation gives our buyers confidence backed by our primary production data.
By maintaining direct communication lines between our technical and regulatory staff and clients’ quality assurance teams, we accelerate information flow and reinforce compliance. Periodic review of documentation, retraining, and upgrades based on evolving legislation or customer feedback keep us ahead of regulatory shifts. We have integrated digital systems on the factory floor to link quality documentation to output in real time—reducing errors and closing compliance gaps. Our goal extends beyond product delivery: we aim for a partnership built on technical clarity and reliability at every stage of the supply chain.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725
